Credit Suisse’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $771K | Buy |
69,583
+5,012
| +8% | +$55.5K | ﹤0.01% | 2415 |
|
2023
Q4 | $559K | Buy |
64,571
+10,929
| +20% | +$94.6K | ﹤0.01% | 2671 |
|
2023
Q3 | $410K | Buy |
53,642
+19,536
| +57% | +$149K | ﹤0.01% | 2779 |
|
2023
Q2 | $246K | Buy |
34,106
+4,158
| +14% | +$29.9K | ﹤0.01% | 3047 |
|
2023
Q1 | $182K | Sell |
29,948
-11,581
| -28% | -$70.5K | ﹤0.01% | 3117 |
|
2022
Q4 | $181K | Sell |
41,529
-333
| -0.8% | -$1.45K | ﹤0.01% | 3199 |
|
2022
Q3 | $164K | Buy |
41,862
+18,961
| +83% | +$74.3K | ﹤0.01% | 3293 |
|
2022
Q2 | $117K | Buy |
22,901
+2
| +0% | +$10 | ﹤0.01% | 3488 |
|
2022
Q1 | $147K | Buy |
22,899
+125
| +0.5% | +$802 | ﹤0.01% | 3422 |
|
2021
Q4 | $183K | Buy |
+22,774
| New | +$183K | ﹤0.01% | 3459 |
|